SAM #140-0176

USPTO market research for a nationwide counterfeit medicines and medical devices awareness campaign

The USPTO is seeking market information from communications providers for a potential nationwide campaign addressing counterfeit medicines and medical devices. - Government buyer: U.S. Department of Commerce, United States Patent and Trademark Office (USPTO), Office of Public Affairs (OPIA). - Potential services: Campaign strategy; educational content and public-facing materials; public service announcements; video and creative communications; digital and social media; media and influencer outreach; and support for a campaign microsite. - Purpose and notable requirements: Raise awareness of the dangers of counterfeit pharmaceuticals and medical devices falsely presented as products made or distributed by legitimate companies. Respondents should demonstrate relevant pharmaceutical or medical-device campaign experience and describe outreach, staffing, performance measures, and risk mitigation. - OEMs, vendors, quantities, and part numbers: None are specified. No quantities or product part numbers are provided. - Opportunity status: This is an RFI for market research, not a solicitation or commitment to procure.

Description

THIS IS A PTAG SOURCES SOUGHT REQUEST FOR INFORMATION (RFI) ONLY.

In accordance with the Patent and Trademark Office Efficiency Act (PTOEA), 35 U.S.C. § 2(b)(4)(A), this Sources Sought Notice Request for Information) (RFI) is strictly for market research ONLY.  It is for informational and planning purposes and shall NOT be construed as a solicitation or as an obligation or commitment by the Government at this time.

This RFI is being made available under NAICS 541820 - Public Relations Agencies.

This effort is for campaign services to support a nationwide public awareness campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices.

The USPTO is seeking information from qualified vendors regarding capabilities and relevant experience to support potential public relations services to create and execute a nationwide public awareness campaign consisting of media relations, videos, and other creative communications deliverables including a microsite and social media campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices that are falsely represented as products made or distributed by real pharmaceutical and medical device companies.

Submission Instructions:

Questions due: no later than October 26, 2026 at 1pm ET 

RFI Response Due Date: November 6, 2026 10am ET

All details are located within the PDF attachment.   

Additional Links:SAM.gov entity registration

View original listing